Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
Top Cited Papers
- 17 May 2010
- journal article
- clinical trial
- Published by Elsevier
- Vol. 203 (3) , 228.e1-228.e6
- https://doi.org/10.1016/j.ajog.2010.03.043
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic massPublished by Elsevier ,2009
- Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer PatientsJNCI Journal of the National Cancer Institute, 2006
- Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitalsInternational Journal of Gynecologic Cancer, 2006
- Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinomaCancer, 2005
- Who should operate on patients with ovarian cancer? An evidence-based reviewGynecologic Oncology, 2005
- A Population-Based Study of Patterns of Care for Ovarian Cancer: Who Is Seen by a Gynecologic Oncologist and Who Is Not?Gynecologic Oncology, 2002
- Stage IV Ovarian Cancer: Impact of Surgical Debulking1Gynecologic Oncology, 1997
- National Institutes of Health Consensus Development Conference StatementGynecologic Oncology, 1994
- A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancerBJOG: An International Journal of Obstetrics and Gynaecology, 1990
- A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian CancerNew England Journal of Medicine, 1983